Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19 — Stella

Recruiting

Back to PASC Post Acute Sequelae of COVID 19 trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Taiwan

Renhe nursing home, New Taipei City

Fuxi nursing home, Taipei

Key details

Sponsor

POCHIWU

Enrollment target

~80 participants

Started

December 2024

Primary completion

April 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years – 100 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov